compounding HOTLINE

AUGUST 01, 2007
Martin A. Erickson III, RPh
A patient complained of redness at the site of application of a topical, transdermal (poloxamer-lecithin organogel?based) preparation. The patient applied the same material at the same site over the past 6 months. Suggestions?
Click Here For The Answer -----------> [-]
Generally, patients should be encouraged to rotate sites of application of extemporaneously prepared formulations intended for transdermal administration of active ingredients, particularly when occlusive dressing technique is employed. Consult with the patient about areas where the epidermis is thin and where hair growth is thinnest.


SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.